BioNTech (BNTX) PT Lowered to $120 at Goldman Sachs
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $101.61 --0%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 19
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 19
Join SI Premium – FREE
Goldman Sachs analyst Chris Shibutani lowered the price target on BioNTech (NASDAQ: BNTX) to $120.00 (from $140.00) while maintaining a Neutral rating.
You May Also Be Interested In
- BioNTech (BNTX) PT Lowered to $136 at Canaccord
- Japan Tobacco Inc. (2914:JP) (JAPAY) PT Raised to JPY8,000 at JPMorgan
- NEXTDC Ltd. (NXT:AU) PT Raised to AUD19.70 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
